Evidence map›Paper›PMID 37111543›Full record

ReviewPharmaceutics2023

Ashwagandha

Paulina Mikulska, Marta Malinowska, Miłosz Ignacyk, Paweł Szustowski, Joanna Nowak, Karolina Pesta, Monika Szeląg, Damian Szklanny, Eliza Judasz, Gabriela Kaczmarek and 4 more

Open access · goldAbstract readReview
In one paragraph

Review in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 136 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
136citing papers in PubMed, 5 pooled it
96.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

136 citing papers in PubMed, 5 syntheses or guidelines pooled it, 242 citations in OpenAlex.

  1. Pooled it
  2. Effects ofNutrients · 2026
    Pooled it
  3. Effects ofFrontiers in pharmacology · 2026
    Pooled it
  4. Pooled it
  5. Effects ofNutrients · 2023
    Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Safety and tolerability of Ashwagandha (Frontiers in nutrition · 2026
    Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Chitosan activates a sequential CaPlant signaling & behavior · 2026
    Article
  17. Review
  18. Article
  19. Review
  20. Plant Part-Specific Differences in Ashwagandha (Food science & nutrition · 2026
    Review

76 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Paulina MikulskaDepartment of Pharmacognosy, Faculty of Pharmacy, Poznań University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland.
Marta MalinowskaDepartment of Pharmacognosy, Faculty of Pharmacy, Poznań University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland.
Miłosz IgnacykDepartment of Pharmacognosy, Faculty of Pharmacy, Poznań University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland.
Paweł SzustowskiDepartment of Pharmacognosy, Faculty of Pharmacy, Poznań University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland.
Joanna NowakDepartment of Pharmacognosy, Faculty of Pharmacy, Poznań University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland.
Karolina PestaDepartment of Pharmacognosy, Faculty of Pharmacy, Poznań University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland.
Monika SzelągDepartment of Pharmacognosy, Faculty of Pharmacy, Poznań University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland.
Damian SzklannyDepartment of Pharmacognosy, Faculty of Pharmacy, Poznań University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland.
Eliza JudaszDepartment of Pharmacognosy, Faculty of Pharmacy, Poznań University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland.
Gabriela KaczmarekDepartment of Pharmacognosy, Faculty of Pharmacy, Poznań University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland.
Ovinuchi Prince EjiohuoDepartment of Pharmacognosy, Faculty of Pharmacy, Poznań University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland.ORCID 0000-0003-2153-7205
Magdalena Paczkowska-WalendowskaDepartment of Pharmacognosy, Faculty of Pharmacy, Poznań University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland.ORCID 0000-0002-0418-9336
Anna GościniakDepartment of Pharmacognosy, Faculty of Pharmacy, Poznań University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland.ORCID 0000-0001-8745-5099
Judyta Cielecka-PiontekDepartment of Pharmacognosy, Faculty of Pharmacy, Poznań University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland.ORCID 0000-0003-0891-5419
Poznan University of Medical Sciences · PL

Funding

National Science Center 2020/39/O/NZ7/03441
6 · The paper itself

Abstract

In recent years, there has been a significant surge in reports on the health-promoting benefits of winter cherry

Indexed as

anticancer activityanti-inflammatory activityantimicrobial activityAshwagandhaherbal medicineplant extractwinter cherryWithania somnifera

Identifiers

PMID37111543
PMCPMC10147008
OpenAlexW4360850703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.